DOCSLIB.ORG

Structural Insights Into the Apkc Regulatory Switch Mechanism of the Human Cell Polarity Protein Lethal Giant Larvae 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Insights Into the Apkc Regulatory Switch Mechanism of the Human Cell Polarity Protein Lethal Giant Larvae 2 Structural insights into the aPKC regulatory switch mechanism of the human cell polarity protein lethal giant larvae 2 Lior Almagora,b, Ivan S. Ufimtseva, Aruna Ayera,b, Jingzhi Lia,b, and William I. Weisa,b,1 aDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305; and bDepartment of Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305 Edited by Wesley I. Sundquist, University of Utah Medical Center, Salt Lake City, UT, and approved March 5, 2019 (received for review December 28, 2018) Metazoan cell polarity is controlled by a set of highly conserved down-regulation of Lgl occurs in various human cancers (18). Lgl proteins. Lethal giant larvae (Lgl) functions in apical-basal polarity has important roles in all aspects of cell polarity, including in the through phosphorylation-dependent interactions with several development of epithelial apical-basal polarity, asymmetrical cell other proteins as well as the plasma membrane. Phosphorylation division, and cell migration. of Lgl by atypical protein kinase C (aPKC), a component of the The molecular basis of Lgl function in cell polarity is poorly partitioning-defective (Par) complex in epithelial cells, excludes Lgl understood, but it is clear that it depends upon aPKC phosphorylation- from the apical membrane, a crucial step in the establishment of dependent cellular localization. In early stages of Drosophila epithelial cell polarity. We present the crystal structures of human epithelial development, when polarity is being established, Lgl is Lgl2 in both its unphosphorylated and aPKC-phosphorylated states. both cytoplasmic and uniformly localized at the cell cortex. At Lgl2 adopts a double β-propeller structure that is unchanged by later stages, aPKC phosphorylation excludes Lgl from the apical aPKC phosphorylation of an unstructured loop in its second β-pro- domain, where Par-6 and aPKC concentrate. This apical exclu- peller, ruling out models of phosphorylation-dependent conforma- sion does not occur in a nonphosphorylatable mutant Lgl, which tional change. We demonstrate that phosphorylation controls the results in aberrant polarity (19). In fully polarized cells, Lgl is direct binding of purified Lgl2 to negative phospholipids in vitro. We located mostly at the lateral membrane, where it actively excludes also show that a coil–helix transition of this region that is promoted Par-6 from the cell cortex (19). A similar spatial and temporal by phosphatidylinositol 4,5-bisphosphate (PIP2) is also phosphorylation- localization of Lgl in relation to the aPKC/Par-6 complex is also dependent, implying a highly effective phosphorylative switch for observed in mammalian epithelial cultures (20). membrane association. In a polarized epithelial cell, Lgl colocalizes with the polarity proteins scribble (Scrib) and discs large (Dlg) at the apical margin Lgl | cell polarity | aPKC of the lateral membrane. Experiments in Drosophila have dem- onstrated a strong genetic interaction among these three genes, he development of structurally and functionally distinct cell indicating that they act together in a common pathway in the Tsurfaces is essential for the proper function of most animal regulation of cell polarity (21). Lgl and Dlg mutations have been cells. The establishment and maintenance of such cell polarity shown to produce similar effects on fly development (21), and a require a set of so-called polarity proteins, whose core compo- nents are conserved throughout metazoa. In epithelial cells, Significance apicobasal polarity is controlled by the spatial and temporal cross-talk between polarity complexes located on the apical or – Epithelial cells have a spatially polarized organization. For ex- basolateral membranes, as well as the cell cell junctions that ample, one surface of an intestinal epithelial cell, called the delineate these membrane domains (1, 2). A central modulator apical side, faces the lumen of the gut and has a membrane of this process is atypical protein kinase C (aPKC) (3). aPKC composition distinct from those of the basolateral sides. robustly interacts with partitioning-defective 6 (Par-6), and they Several proteins that control the development and mainte- are found together in a subapical epithelial region in complex nance of apical-basolateral polarity have been identified, but with the aPKC substrate Par-3 (bazooka in Drosophila) (4, 5). their molecular mechanisms are poorly understood. Lethal The aPKC/Par-6/Par-3 complex is important for the establish- giant larvae (Lgl) is a basolateral polarity protein that is lost ment of apical-basal polarity, as well as for the maturation of selectively from the apical membrane during development, epithelial junctions in Drosophila and mammals. It also has roles due to its phosphorylation by atypical protein kinase C. Here, – in asymmetric cell division (6 8). In Caenorhabditis elegans zy- we describe the 3D structure of Lgl in both its unmodified and gotes, a homologous PKC3/Par-6/Par-3 complex, which localizes phosphorylated states, and show that phosphorylation of Lgl to the anterior half following the entry of the sperm cell, is es- mediates a structural switch that controls its association with sential for anterior/posterior polarity (6). The aPKC/Par-6 com- the plasma membrane. plex also colocalizes with the crumbs/PALS1/PATJ (crumbs/ stardust/discs-lost in Drosophila) polarity complex located at the Author contributions: L.A. and W.I.W. designed research; L.A., I.S.U., and A.A. performed apical domain. This complex is also crucial for the establishment research; I.S.U., A.A., and J.L. contributed new reagents/analytic tools; L.A., I.S.U., and of epithelial apicobasal polarity, and it is likewise regulated by W.I.W. analyzed data; and L.A. and W.I.W. wrote the paper. aPKC phosphorylation (9). The authors declare no conflict of interest. In addition to its roles in the apical polarity complexes, aPKC This article is a PNAS Direct Submission. is responsible for the phosphorylation of other polarity proteins, Published under the PNAS license. including lethal giant larvae (Lgl) (3). First identified in Dro- Data deposition: The atomic coordinates and structure factors have been deposited in the sophila genetic screens, lgl mutant flies develop cancer-like de- Protein Data Bank, www.wwpdb.org (PDB ID codes 6N8P, 6N8Q, 6N8R, and 6N8S). fects, leading to uncontrolled growth of larval brain neuroblasts 1To whom correspondence should be addressed. Email: [email protected]. and imaginal discs (10–13). Lgl is conserved in eukaryotes and This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. can be found in two isoforms in mammals (14). Its mutations 1073/pnas.1821514116/-/DCSupplemental. result in polarity defects in mice and other animals (15–17), and Published online May 14, 2019. 10804–10812 | PNAS | May 28, 2019 | vol. 116 | no. 22 www.pnas.org/cgi/doi/10.1073/pnas.1821514116 Downloaded by guest on September 23, 2021 direct low-affinity interaction between the guanylate kinase do- by multiple serine phosphorylations in the aPKC target site could main of human Dlg4 and a Lgl2 peptide containing phosphory- be the major determinant of membrane targeting and/or protein– lated aPKC target sites has been characterized biochemically and protein interaction. structurally (22). Interactions between Scrib and Lgl have also Here, we report crystal structures of human Lgl2 in both its been demonstrated (23), but strong biochemical evidence for the phosphorylated and unphosphorylated forms. Our structural existence of a ternary Lgl/Dlg/Scrib complex is lacking. Interaction results confirm the double β-propeller core structure for Lgl2. of Lgl, controlled by aPKC phosphorylation, has been reported There are no apparent structural variations between the with additional targets, including nonmuscle myosin II (NMII) unphosphorylated and phosphorylated states of the protein. We (15, 24, 25), syntaxin4 (26, 27), and others (28–32). In addition to demonstrate the preferential interaction of Lgl2 protein with aPKC, cytoplasmic Lgl is phosphorylated by the aurora A and B phosphatidylinositol 4,5-bisphosphate (PIP2)-containing mem- kinases at mitosis in epithelial cells, which promotes its mitotic branes that is abolished by aPKC phosphorylation, as previously relocalization (33–35). demonstrated with a polybasic peptide fragment of this loop (41, Budding yeast express the Lgl homolog Sro7, a 1,033-residue 42). We also show that a coil–helix transformation of this region, protein that is essential for polarized exocytosis in bud growth promoted by PIP2, is phosphorylation-dependent, which implies (36). The Sro7 structure (37) comprises 14 WD40 repeats arranged an effective membrane switch mechanism. These results set a in two seven bladed β-propeller barrels. The distant Lgl/Sro7 se- firm basis for understanding the mechanistic roles of Lgl in quence homology (∼10% identity) suggests them to be structurally cell polarity. and functionally related. Mouse Lgl1 was shown to partially rescue low salt tolerance and temperature sensitivity associated with the Results loss of Sro7 and its homolog, Sro77 (38, 39). The role of Lgl in Structure of Lgl2. To explore the structure of Lgl in its different exocytosis in vertebrates has yet to be solidly established, however. functional forms, we crystallized human Lgl2 both in its The target serine-rich sequence for aPKC phosphorylation unphosphorylated state and in its in vitro aPKCι-phosphorylated
Load more

Recommended publications
  • Cell Division Symmetry Control and Cancer Stem Cells
    AIMS Molecular Science, 7(2): 82–98. DOI: 10.3934/molsci.2020006 Received: 15 February 2020 Accepted: 26 April 2020 Published: 06 May 2020 http://www.aimspress.com/journal/Molecular Review Cell division symmetry control and cancer stem cells Sreemita Majumdar and Song-Tao Liu* Department of Biological Sciences, University of Toledo, Toledo, OH 43606, USA * Correspondence: Email: [email protected]; Tel: +14195307853. Table S1. Genes encoding polarity and fate-determinant proteins involved in asymmetric cell division. C. elegans1 D. melanogaster 1 Mammals1 Description2 Associated with/ Interactors 3 Cellular Localization (mammalian cell)4 Serine/threonine protein microtubule-associated protein cell membrane, peripheral and lateral, par-1 par-1 MARK1/2/3/4 kinase MAPT/TAU cytoplasm, dendrite RING, Lipid binding par-2 - - domain PDZ for membrane, cell junction, adherens junction, cell cortex, par-3 baz PARD3 Oligomerization domain at actin, PARD6 endomembrane system, NTD Continued on next page 2 C. elegans1 D. melanogaster 1 Mammals1 Description2 Associated with/ Interactors 3 Cellular Localization (mammalian cell)4 Serine/threonine-protein nucleus, mitochondria, cytoplasm, par-4 Lkb1 STK11/LKB1 STRAD complex kinase membrane 14-3-3 domain binding par-5 14-3-3 YWHAB phosphoserine/ adapter to many proteins cytoplasm phosphothreonine motif cell membrane, centriolar satellite, actin par-6 par-6 PARD6A/B/G PB1, CRIB, PDZ PARD3 cytoskeleton,centrosome, cytoplasm ,ruffles PARD3, and a PARD6 protein PB1, AGC-Kinase (PARD6A, PARD6B or PARD6G) pkc-3 aPKC PRKCI/Z domain, DAG binding, cytoplasm, nucleus, membrane and a GTPase protein (CDC42 or Zinc finger domain RAC1), LLGL1,ECT2 LRR and PDZ protein Cadherin, Scrib-APC-beta-catenin nucleoplasm, basolateral plasma membrane, let-413 scrib SCRIB family.
    [Show full text]
  • Genes in a Refined Smith-Magenis Syndrome Critical Deletion Interval on Chromosome 17P11.2 and the Syntenic Region of the Mouse
    Downloaded from genome.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press Article Genes in a Refined Smith-Magenis Syndrome Critical Deletion Interval on Chromosome 17p11.2 and the Syntenic Region of the Mouse Weimin Bi,1,6 Jiong Yan,1,6 Paweł Stankiewicz,1 Sung-Sup Park,1,7 Katherina Walz,1 Cornelius F. Boerkoel,1 Lorraine Potocki,1,3 Lisa G. Shaffer,1 Koen Devriendt,4 Małgorzata J.M. Nowaczyk,5 Ken Inoue,1 and James R. Lupski1,2,3,8 Departments of 1Molecular & Human Genetics, 2Pediatrics, Baylor College of Medicine, 3Texas Children’s Hospital, Houston, Texas 77030, USA; 4Centre for Human Genetics, University Hospital Gasthuisberg, Catholic University of Leuven, B-3000 Leuven, Belgium; 5Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario L8S 4J9, Canada Smith-Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome associated with behavioral abnormalities and sleep disturbance. Most patients have the same ∼4 Mb interstitial genomic deletion within chromosome 17p11.2. To investigate the molecular bases of the SMS phenotype, we constructed BAC/PAC contigs covering the SMS common deletion interval and its syntenic region on mouse chromosome 11. Comparative genome analysis reveals the absence of all three ∼200-kb SMS-REP low-copy repeats in the mouse and indicates that the evolution of SMS-REPs was accompanied by transposition of adjacent genes. Physical and genetic map comparisons in humans reveal reduced recombination in both sexes. Moreover, by examining the deleted regions in SMS patients with unusual-sized deletions, we refined the minimal Smith-Magenis critical region (SMCR) to an ∼1.1-Mb genomic interval that is syntenic to an ∼1.0-Mb region in the mouse.
    [Show full text]
  • Distinct Genetic Alterations in Colorectal Cancer
    Distinct Genetic Alterations in Colorectal Cancer Hassan Ashktorab1*, Alejandro A. Scha¨ffer2, Mohammad Daremipouran3, Duane T. Smoot3, Edward Lee3, Hassan Brim3 1 Department of Medicine and Cancer Center, Howard University, College of Medicine, Washington, DC, United States of America, 2 National Center for Biotechnology Information, National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, Maryland, United States of America, 3 Department of Pathology, Howard University, College of Medicine, Washington, DC, United States of America Abstract Background: Colon cancer (CRC) development often includes chromosomal instability (CIN) leading to amplifications and deletions of large DNA segments. Epidemiological, clinical, and cytogenetic studies showed that there are considerable differences between CRC tumors from African Americans (AAs) and Caucasian patients. In this study, we determined genomic copy number aberrations in sporadic CRC tumors from AAs, in order to investigate possible explanations for the observed disparities. Methodology/Principal Findings: We applied genome-wide array comparative genome hybridization (aCGH) using a 105k chip to identify copy number aberrations in samples from 15 AAs. In addition, we did a population comparative analysis with aCGH data in Caucasians as well as with a widely publicized list of colon cancer genes (CAN genes). There was an average of 20 aberrations per patient with more amplifications than deletions. Analysis of DNA copy number of frequently altered chromosomes revealed that deletions occurred primarily in chromosomes 4, 8 and 18. Chromosomal duplications occurred in more than 50% of cases on chromosomes 7, 8, 13, 20 and X. The CIN profile showed some differences when compared to Caucasian alterations. Conclusions/Significance: Chromosome X amplification in male patients and chromosomes 4, 8 and 18 deletions were prominent aberrations in AAs.
    [Show full text]
  • Research Article Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases
    Hindawi Canadian Journal of Gastroenterology and Hepatology Volume 2019, Article ID 2920493, 12 pages https://doi.org/10.1155/2019/2920493 Research Article Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases Alexander Desuki,1,2 Frank Staib ,1,3 Ines Gockel,4 Markus Moehler,1 Hauke Lang,5 Stefan Biesterfeld,6 Annett Maderer,1 Peter R. Galle ,1 Martin R. Berger,7 and Carl C. Schimanski 1,8 1 First Department of Internal Medicine, Johannes Gutenberg University, Langenbeckstraße 1, 55131 Mainz, Germany 2Tird Department of Internal Medicine, Johannes Gutenberg University, 55131 Mainz, Germany 3Department of Internal Medicine, Marienhospital Darmstadt gGmbH, Martinspfad 72, 64285 Darmstadt, Germany 4DepartmentofVisceral,Transplantation,ToracicandVascularSurgery,UniversityofLeipzig,Liebigstraße20, 04103 Leipzig, Germany 5Department of Abdominal and General Surgery, Johannes Gutenberg University, Langenbeckstraße 1, 55131 Mainz, Germany 6Institute of Pathology, Johannes Gutenberg University, Langenbeckstraße 1, 55131 Mainz, Germany 7Toxicology and Chemotherapy Unit, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany 8Second Department of Internal Medicine, Klinikum Darmstadt GmbH, Grafenstraße 9, 64283 Darmstadt, Germany Correspondence should be addressed to Peter R. Galle; [email protected] and Carl C. Schimanski; [email protected] Received 29 May 2018; Accepted 21 February 2019; Published 1 April 2019 Academic Editor: Masanao Nakamura Copyright © 2019 Alexander Desuki et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background.LossofLLGL1 has been associated with loss of cellular adhesion and dissemination of cells from colorectal cancer and malignant melanoma.
    [Show full text]
  • A Model for Profiling the Emolecular Effects of Alcohol
    The Pharmacogenomics Journal (2015) 15, 177–188 © 2015 Macmillan Publishers Limited All rights reserved 1470-269X/15 www.nature.com/tpj ORIGINAL ARTICLE The synaptoneurosome transcriptome: a model for profiling the emolecular effects of alcohol D Most1,2, L Ferguson1,2, Y Blednov1, RD Mayfield1 and RA Harris1 Chronic alcohol consumption changes gene expression, likely causing persistent remodeling of synaptic structures via altered translation of mRNAs within synaptic compartments of the cell. We profiled the transcriptome from synaptoneurosomes (SNs) and paired total homogenates (THs) from mouse amygdala following chronic voluntary alcohol consumption. In SN, both the number of alcohol-responsive mRNAs and the magnitude of fold-change were greater than in THs, including many GABA-related mRNAs upregulated in SNs. Furthermore, SN gene co-expression analysis revealed a highly connected network, demonstrating coordinated patterns of gene expression and highlighting alcohol-responsive biological pathways, such as long-term potentiation, long-term depression, glutamate signaling, RNA processing and upregulation of alcohol-responsive genes within neuroimmune modules. Alterations in these pathways have also been observed in the amygdala of human alcoholics. SNs offer an ideal model for detecting intricate networks of coordinated synaptic gene expression and may provide a unique system for investigating therapeutic targets for the treatment of alcoholism. The Pharmacogenomics Journal (2015) 15, 177–188; doi:10.1038/tpj.2014.43; published online 19 August 2014 INTRODUCTION mRNAs from SN15,16,18,19 and TH samples from mouse amygdala, a Alcohol dependence is a severe and widespread disease. Over 17 brain region known to be involved with the negative reinforce- 20 million Americans suffer from alcohol-related problems; total cost ment of alcohol and other drugs of abuse.
    [Show full text]
  • Genomic Organization of the Approximately 1.5 Mb Smith
    European Journal of Human Genetics (2001) 9, 892 ± 902 ã 2001 Nature Publishing Group All rights reserved 1018-4813/01 $15.00 www.nature.com/ejhg ARTICLE Genomic organisation of the ~1.5 Mb Smith-Magenis syndrome critical interval: Transcription map, genomic contig, and candidate gene analysis Rebecca E Lucas1, Christopher N Vlangos1, Parimal Das4, Pragna I Patel4 and Sarah H Elsea*,1,2,3 1Genetics Graduate Program, Michigan State University, East Lansing, Michigan, MI 48824, USA; 2Department of Zoology, Michigan State University, East Lansing, Michigan, MI 48824, USA; 3Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan, MI 48824, USA; 4Department of Neurology, Baylor College of Medicine, Houston, Texas, TX 77030, USA Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation syndrome associated with an interstitial deletion of chromosome 17 involving band p11.2. SMS is hypothesised to be a contiguous gene syndrome in which the phenotype arises from the haploinsufficiency of multiple, functionally-unrelated genes in close physical proximity, although the true molecular basis of SMS is not yet known. In this study, we have generated the first overlapping and contiguous transcription map of the SMS critical interval, linking the proximal 17p11.2 region near the SMS-REPM and the distal region near D17S740 in a minimum tiling path of 16 BACs and two PACs. Additional clones provide greater coverage throughout the critical region. Not including the repetitive sequences that flank the critical interval, the map is comprised of 13 known genes, 14 ESTs, and six genomic markers, and is a synthesis of Southern hybridisation and polymerase chain reaction data from gene and marker localisation to BACs and PACs and database sequence analysis from the human genome project high-throughput draft sequence.
    [Show full text]
  • In This Table Protein Name, Uniprot Code, Gene Name P-Value
    Supplementary Table S1: In this table protein name, uniprot code, gene name p-value and Fold change (FC) for each comparison are shown, for 299 of the 301 significantly regulated proteins found in both comparisons (p-value<0.01, fold change (FC) >+/-0.37) ALS versus control and FTLD-U versus control. Two uncharacterized proteins have been excluded from this list Protein name Uniprot Gene name p value FC FTLD-U p value FC ALS FTLD-U ALS Cytochrome b-c1 complex P14927 UQCRB 1.534E-03 -1.591E+00 6.005E-04 -1.639E+00 subunit 7 NADH dehydrogenase O95182 NDUFA7 4.127E-04 -9.471E-01 3.467E-05 -1.643E+00 [ubiquinone] 1 alpha subcomplex subunit 7 NADH dehydrogenase O43678 NDUFA2 3.230E-04 -9.145E-01 2.113E-04 -1.450E+00 [ubiquinone] 1 alpha subcomplex subunit 2 NADH dehydrogenase O43920 NDUFS5 1.769E-04 -8.829E-01 3.235E-05 -1.007E+00 [ubiquinone] iron-sulfur protein 5 ARF GTPase-activating A0A0C4DGN6 GIT1 1.306E-03 -8.810E-01 1.115E-03 -7.228E-01 protein GIT1 Methylglutaconyl-CoA Q13825 AUH 6.097E-04 -7.666E-01 5.619E-06 -1.178E+00 hydratase, mitochondrial ADP/ATP translocase 1 P12235 SLC25A4 6.068E-03 -6.095E-01 3.595E-04 -1.011E+00 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 MIC J3QTA6 CHCHD6 1.090E-04 -5.913E-01 2.124E-03 -5.948E-01 Protein kinase C and casein Q9BY11 PACSIN1 3.837E-03 -5.863E-01 3.680E-06 -1.824E+00 kinase substrate in neurons protein 1 Tubulin polymerization- O94811 TPPP 6.466E-03 -5.755E-01 6.943E-06 -1.169E+00 promoting protein MIC C9JRZ6 CHCHD3 2.912E-02 -6.187E-01 2.195E-03 -9.781E-01 Mitochondrial 2-
    [Show full text]
  • Mdm2-Mediated Ubiquitylation: P53 and Beyond
    Cell Death and Differentiation (2010) 17, 93–102 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Review Mdm2-mediated ubiquitylation: p53 and beyond J-C Marine*,1 and G Lozano2 The really interesting genes (RING)-finger-containing oncoprotein, Mdm2, is a promising drug target for cancer therapy. A key Mdm2 function is to promote ubiquitylation and proteasomal-dependent degradation of the tumor suppressor protein p53. Recent reports provide novel important insights into Mdm2-mediated regulation of p53 and how the physical and functional interactions between these two proteins are regulated. Moreover, a p53-independent role of Mdm2 has recently been confirmed by genetic data. These advances and their potential implications for the development of new cancer therapeutic strategies form the focus of this review. Cell Death and Differentiation (2010) 17, 93–102; doi:10.1038/cdd.2009.68; published online 5 June 2009 Mdm2 is a key regulator of a variety of fundamental cellular has also emerged from recent genetic studies. These processes and a very promising drug target for cancer advances and their potential implications for the development therapy. It belongs to a large family of (really interesting of new cancer therapeutic strategies form the focus of this gene) RING-finger-containing proteins and, as most of its review. For a more detailed discussion of Mdm2 and its other members, Mdm2 functions mainly, if not exclusively, as various functions an interested reader should also consult an E3 ligase.1 It targets various substrates for mono- and/or references9–12. poly-ubiquitylation thereby regulating their activities; for instance by controlling their localization, and/or levels by The p53–Mdm2 Regulatory Feedback Loop proteasome-dependent degradation.
    [Show full text]
  • "The Genecards Suite: from Gene Data Mining to Disease Genome Sequence Analyses". In: Current Protocols in Bioinformat
    The GeneCards Suite: From Gene Data UNIT 1.30 Mining to Disease Genome Sequence Analyses Gil Stelzer,1,5 Naomi Rosen,1,5 Inbar Plaschkes,1,2 Shahar Zimmerman,1 Michal Twik,1 Simon Fishilevich,1 Tsippi Iny Stein,1 Ron Nudel,1 Iris Lieder,2 Yaron Mazor,2 Sergey Kaplan,2 Dvir Dahary,2,4 David Warshawsky,3 Yaron Guan-Golan,3 Asher Kohn,3 Noa Rappaport,1 Marilyn Safran,1 and Doron Lancet1,6 1Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel 2LifeMap Sciences Ltd., Tel Aviv, Israel 3LifeMap Sciences Inc., Marshfield, Massachusetts 4Toldot Genetics Ltd., Hod Hasharon, Israel 5These authors contributed equally to the paper 6Corresponding author GeneCards, the human gene compendium, enables researchers to effectively navigate and inter-relate the wide universe of human genes, diseases, variants, proteins, cells, and biological pathways. Our recently launched Version 4 has a revamped infrastructure facilitating faster data updates, better-targeted data queries, and friendlier user experience. It also provides a stronger foundation for the GeneCards suite of companion databases and analysis tools. Improved data unification includes gene-disease links via MalaCards and merged biological pathways via PathCards, as well as drug information and proteome expression. VarElect, another suite member, is a phenotype prioritizer for next-generation sequencing, leveraging the GeneCards and MalaCards knowledgebase. It au- tomatically infers direct and indirect scored associations between hundreds or even thousands of variant-containing genes and disease phenotype terms. Var- Elect’s capabilities, either independently or within TGex, our comprehensive variant analysis pipeline, help prepare for the challenge of clinical projects that involve thousands of exome/genome NGS analyses.
    [Show full text]
  • Novel Mechanisms of Spinal Cord Plasticity in a Mouse Model of Motoneuron Disease
    Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 654637, 10 pages http://dx.doi.org/10.1155/2015/654637 Research Article Novel Mechanisms of Spinal Cord Plasticity in a Mouse Model of Motoneuron Disease Rosario Gulino,1,2 Rosalba Parenti,1 and Massimo Gulisano1 1 Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 64, 95127 Catania, Italy 2IOM Ricerca s.r.l., Via Penninazzo 11, 95029 Viagrande, Italy Correspondence should be addressed to Rosario Gulino; [email protected] Received 26 September 2014; Accepted 16 December 2014 Academic Editor: Andrea Vecchione Copyright © 2015 Rosario Gulino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A hopeful spinal cord repairing strategy involves the activation of neural precursor cells. Unfortunately, their ability to generate neurons after injury appears limited. Another process promoting functional recovery is synaptic plasticity. We have previously studied some mechanisms of spinal plasticity involving BDNF, Shh, Notch-1, Numb, and Noggin, by using a mouse model of motoneuron depletion induced by cholera toxin-B saporin. TDP-43 is a nuclear RNA/DNA binding protein involved in amyotrophic lateral sclerosis. Interestingly, TDP-43 could be localized at the synapse and affect synaptic strength. Here, we would like to deepen the investigation of this model of spinal plasticity. After lesion, we observed a glial reaction and an activity-dependent modification of Shh, Noggin, and Numb proteins. By using multivariate regression models, we found that Shh and Noggin could affect motor performance and that these proteins could be associated with both TDP-43 and Numb.
    [Show full text]
  • 12159 LLGL1 (D2B5A) Rabbit Mab
    Revision 1 C 0 2 - t LLGL1 (D2B5A) Rabbit mAb a e r o t S Orders: 877-616-CELL (2355) [email protected] 9 Support: 877-678-TECH (8324) 5 1 Web: [email protected] 2 www.cellsignal.com 1 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source/Isotype: UniProt ID: Entrez-Gene Id: WB, IF-IC H Mk Endogenous 130 Rabbit IgG Q15334 3996 Product Usage Information 1. Agrawal, N. et al. (1995) Dev Biol 172, 218-29. 2. Massimi, P. et al. (2008) Exp Cell Res 314, 3306-17. Application Dilution 3. Strand, D. et al. (1995) Oncogene 11, 291-301. 4. Schimanski, C.C. et al. (2005) Oncogene 24, 3100-9. Western Blotting 1:1000 5. Kuphal, S. et al. (2006) Oncogene 25, 103-10. Immunofluorescence (Immunocytochemistry) 1:50 6. Lu, X. et al. (2009) Clin Cancer Res 15, 3287-96. 7. Müsch, A. et al. (2002) Mol Biol Cell 13, 158-68. 8. Yamanaka, T. et al. (2003) Curr Biol 13, 734-43. Storage 9. Mechler, B.M. et al. (1985) EMBO J 4, 1551-7. Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% 10. Sripathy, S. et al. (2011) Mol Cell Biol 31, 2920-33. glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody. Specificity / Sensitivity LLGL1 (D2B5A) Rabbit mAb recognizes endogenous levels of total LLGL1 protein. This antibody does not cross-react with LLGL2.
    [Show full text]
  • LLGL1 Rabbit Pab
    Leader in Biomolecular Solutions for Life Science LLGL1 Rabbit pAb Catalog No.: A20205 Basic Information Background Catalog No. This gene encodes a protein that is similar to a tumor suppressor in Drosophila. The protein A20205 is part of a cytoskeletal network and is associated with nonmuscle myosin II heavy chain and a kinase that specifically phosphorylates this protein at serine residues. The gene is located Observed MW within the Smith-Magenis syndrome region on chromosome 17. 115KDa Calculated MW 112kDa Category Primary antibody Applications WB, IHC, IF Cross-Reactivity Human, Mouse, Rat Recommended Dilutions Immunogen Information WB 1:500 - 1:2000 Gene ID Swiss Prot 3996 Q15334 IHC 1:50 - 1:200 Immunogen IF 1:50 - 1:200 Recombinant fusion protein containing a sequence corresponding to amino acids 945-1064 of human LLGL1 (NP_004131.3). Synonyms DLG4; HUGL; LLGL; Lgl1; Mgl1; HUGL1; HUGL-1 Contact Product Information 400-999-6126 Source Isotype Purification Rabbit IgG Affinity purification [email protected] Storage www.abclonal.com.cn Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3. Validation Data Western blot analysis of extracts of various cell lines, using LLGL1 antibody (A20205) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit (RM00020). Exposure time: 10s. Western blot analysis of extracts of Rat testis, using LLGL1 antibody (A20205) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (AS014) at 1:10000 dilution.
    [Show full text]